MaiMarFX | Feb 22, 2021 04:58AM ET
Positive market sentiment continued as investors took comfort from positive news on vaccine efficacy. In Israel, the Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) Covid-19 shot appeared to stop the vast majority of recipients from infection.
The anti-risk U.S. dollar turned lower amid optimism about the global recovery. The pound sterling extended its gains until a high of 1.4052 despite its overbought trading levels. The euro traded steady between 1.21 and 1.2150.
This week investors will be monitoring Federal Reserve Chair Jerome Powell’s testimony on Tuesday. Powell is likely to emphasize a dovish message to Congress in his testimony, stressing that now is not the time to talk about normalizing policy.
The pound traded on a high note as the nearing reopening of the U.K. economy provides a tailwind for the currency. While the risk of pullbacks remains amid overbought territory, the overall uptrend could favor higher targets at 1.42 and 1.4330. If the pound is able to stabilize above the 1.4050-barrier, we will focus on a higher target at 1.4170. For bearish momentum to accelerate we will need to see a break below 1.39. A crucial support is still seen at around 1.3750.
Disclaimer: All trading ideas and expressions of opinion made in the articles are the personal opinion and assumption of MaiMarFX traders. They are not meant to be a solicitation or recommendation to buy or sell a specific financial instrument.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.